{"t":"DOCUMENT","c":"","l":0,"ch":[{"t":"CONTAINER","c":"html","l":1,"ch":[{"t":"CONTAINER","c":"head","l":2,"ch":[{"t":"CONTAINER","c":"title","l":3,"ch":[{"t":"SECTION_TITLE","c":"8-K","l":4}]},{"t":"CONTAINER","c":"meta","l":3}]},{"t":"CONTAINER","c":"body","l":2,"ch":[{"t":"CONTAINER","c":"div","l":3,"ch":[{"t":"CONTAINER","c":"ix:header","l":4,"ch":[{"t":"CONTAINER","c":"ix:hidden","l":5,"ch":[{"t":"CONTAINER","c":"ix:nonnumeric","l":6,"ch":[{"t":"SECTION_TITLE","c":"false","l":7}]},{"t":"CONTAINER","c":"ix:nonnumeric","l":6,"ch":[{"t":"SECTION_TITLE","c":"0001479290","l":7}]},{"t":"CONTAINER","c":"ix:nonnumeric","l":6,"ch":[{"t":"SECTION_TITLE","c":"--12-31","l":7}]}]},{"t":"CONTAINER","c":"ix:references","l":5,"ch":[{"t":"CONTAINER","c":"link:schemaref","l":6}]},{"t":"CONTAINER","c":"ix:resources","l":5,"ch":[{"t":"CONTAINER","c":"xbrli:context","l":6,"ch":[{"t":"CONTAINER","c":"xbrli:entity","l":7,"ch":[{"t":"CONTAINER","c":"xbrli:identifier","l":8,"ch":[{"t":"SECTION_TITLE","c":"0001479290","l":9}]}]},{"t":"CONTAINER","c":"xbrli:period","l":7,"ch":[{"t":"CONTAINER","c":"xbrli:startdate","l":8,"ch":[{"t":"SECTION_TITLE","c":"2025-02-06","l":9}]},{"t":"CONTAINER","c":"xbrli:enddate","l":8,"ch":[{"t":"SECTION_TITLE","c":"2025-02-06","l":9}]}]}]}]}]}]},{"t":"CONTAINER","c":"div","l":3,"ch":[{"t":"CONTAINER","c":"div","l":4,"ch":[{"t":"PARAGRAPH","c":"p","l":5},{"t":"PARAGRAPH","c":"p","l":5},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"UNITED STATES","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"SECURITIES AND EXCHANGE COMMISSION","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"WASHINGTON, D.C. 20549","l":6}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"CONTAINER","c":"div","l":5,"ch":[{"t":"PARAGRAPH","c":"p","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"ix:nonnumeric","l":6,"ch":[{"t":"SECTION_TITLE","c":"8-K","l":7}]}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"CONTAINER","c":"div","l":5,"ch":[{"t":"PARAGRAPH","c":"p","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"CURRENT REPORT","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"Pursuant to Section 13 or 15(d)","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"of the Securities Exchange Act of 1934","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"ix:nonnumeric","l":6,"ch":[{"t":"SECTION_TITLE","c":"February 6, 2025","l":7}]}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"CONTAINER","c":"div","l":5,"ch":[{"t":"PARAGRAPH","c":"p","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"Revance Therapeutics, Inc.","l":6},{"t":"CONTAINER","c":"ix:nonnumeric","l":6,"ch":[{"t":"SECTION_TITLE","c":"Revance Therapeutics, Inc.","l":7}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"(Exact name of registrant as specified in charter)","l":6}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"CONTAINER","c":"div","l":5,"ch":[{"t":"PARAGRAPH","c":"p","l":6}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"TABLE","c":"table","l":5,"ch":[{"t":"TABLE","c":"table","l":6,"ch":[{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"Delaware","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"001-36297","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"77-0551645","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"(State or other jurisdictionof incorporation)","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"(CommissionFile Number)","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"(IRS EmployerIdentification No.)","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"TABLE","c":"table","l":5,"ch":[{"t":"TABLE","c":"table","l":6,"ch":[{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"1222 Demonbreun Street,Suite 2000,Nashville,Tennessee,37203","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"(Address of principal executive offices and zip code)","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"ix:nonnumeric","l":6,"ch":[{"t":"SECTION_TITLE","c":"(615)","l":7}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"724-7755","l":7},{"t":"CONTAINER","c":"ix:nonnumeric","l":7,"ch":[{"t":"SECTION_TITLE","c":"724-7755","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"(Registrant’s telephone number, including area code)","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"(Former name or former address, if changed since last report)","l":6}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"CONTAINER","c":"div","l":5,"ch":[{"t":"PARAGRAPH","c":"p","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"8-K","l":7}]}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"TABLE","c":"table","l":5,"ch":[{"t":"TABLE","c":"table","l":6,"ch":[{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"☐","l":8},{"t":"TABLE_CELL","c":"Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"TABLE","c":"table","l":5,"ch":[{"t":"TABLE","c":"table","l":6,"ch":[{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"☐","l":8},{"t":"TABLE_CELL","c":"Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"TABLE","c":"table","l":5,"ch":[{"t":"TABLE","c":"table","l":6,"ch":[{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"☐","l":8},{"t":"TABLE_CELL","c":"Pre-commencementcommunications pursuant to Rule14d-2(b)under the Exchange Act (17 CFR240.14d-2(b))","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"TABLE","c":"table","l":5,"ch":[{"t":"TABLE","c":"table","l":6,"ch":[{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"☐","l":8},{"t":"TABLE_CELL","c":"Pre-commencementcommunications pursuant to Rule13e-4(c)under the Exchange Act (17 CFR240.13e-4(c))","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"Securities registered pursuant to Section 12(b) of the Act:","l":6}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"TABLE","c":"table","l":5,"ch":[{"t":"TABLE","c":"table","l":6,"ch":[{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"Title of each class","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"TradingSymbol(s)","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"Name of each exchangeon which registered","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"Common Stock, $0.001 par value","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"RVNC","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"Nasdaq Global Market","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"12b-2","l":7}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"(§240.12b-2","l":7}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"ix:nonnumeric","l":6,"ch":[{"t":"SECTION_TITLE","c":"☐","l":7}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐","l":6}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"PARAGRAPH","c":"p","l":5},{"t":"PARAGRAPH","c":"p","l":5}]}]},{"t":"PARAGRAPH","c":"p","l":3},{"t":"CONTAINER","c":"hr","l":3},{"t":"CONTAINER","c":"div","l":3,"ch":[{"t":"CONTAINER","c":"div","l":4,"ch":[{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"Introductory Note","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"8-K","l":7}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"SEC","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"SEC","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Revance","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Revance","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Company","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Company","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"A&R Merger Agreement","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"A&R Merger Agreement","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Parent","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Parent","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Merger Sub","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Merger Sub","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Buyer Parties","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Buyer Parties","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Original Agreement","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Original Agreement","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"Item 1.01 Entry into a Material Definitive Agreement.","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Trustee","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Trustee","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"First Supplemental Indenture","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"First Supplemental Indenture","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Indenture","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Indenture","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"2027 Convertible Notes","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"2027 Convertible Notes","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"10-K.","l":7}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"8-K","l":7}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"Item 2.01 Completion of Acquisition or Disposition of Assets","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Offer","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Offer","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Company Common Stock","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Company Common Stock","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Share","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Share","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Shares","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Shares","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Offer Price","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Offer Price","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"The Offer expired as scheduled at one (1) minute after 11:59 p.m., Eastern Time, on February 4, 2025. Computershare Trust Company, N.A., in its capacity as depositary and paying agent for the Offer, advised that, as of the expiration of the Offer, a total of 86,197,893 Shares were validly tendered and not validly withdrawn pursuant to the Offer, representing approximately 82% of the outstanding Shares other than the Excluded Shares. On February 6, 2025, Merger Sub irrevocably accepted for payment all Shares that were validly tendered and not validly withdrawn.","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"DGCL","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"DGCL","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Merger","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Merger","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Transaction","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Transaction","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Effective Time","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Effective Time","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"In addition, at the Effective Time, (i) each Vested Company RSU and Vested Company RSA that is subject to service-based vesting conditions and outstanding or that vests in accordance with its terms as a result of the consummation of the Merger, and each Director RSA was canceled and converted into the right to receive a lump sum payment, without interest thereon and subject to applicable withholding taxes, equal to, (a) with respect to each Vested Company RSU, the product of","l":6}]}]}]},{"t":"PARAGRAPH","c":"p","l":3},{"t":"CONTAINER","c":"hr","l":3},{"t":"CONTAINER","c":"div","l":3,"ch":[{"t":"CONTAINER","c":"div","l":4,"ch":[{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Company Performance Awards","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Company Performance Awards","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Cash Replacement Company RSU Amount","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Cash Replacement Company RSU Amount","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Cash Replacement Company RSA Amount","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Cash Replacement Company RSA Amount","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Cash Replacement Option Amount","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Cash Replacement Option Amount","l":8}]}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Cash Replacement Amount","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Cash Replacement Amount","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"8-K","l":7}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"8-K","l":7}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"8-K","l":7}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"8-K","l":7}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Off-Balance","l":7}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"The consummation of the Transaction constitutes a Share Exchange Event, a Fundamental Change and a Make-Whole Fundamental Change (each as defined in the Indenture) under the Indenture. The effective date of each of the Fundamental Change and the Make-Whole Fundamental Change is February 6, 2025, the date of the consummation of the Transaction. As a result of the Fundamental Change, each holder of 2027 Convertible Notes will have the right to require the Company to repurchase its 2027 Convertible Notes.","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"In addition, as a result of the Make-Whole Fundamental Change and in accordance with the Indenture and Section 2.01 of the First Supplemental Indenture, holders who surrender their 2027 Convertible Notes for conversion from and after the Effective Time at any time when the 2027 Convertible Notes are convertible will receive cash in an amount equal to the Conversion Rate in effect on the Conversion Date (each as defined in the Indenture), multiplied by the Offer Price of $3.65, and will not receive any Shares.","l":6}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"TABLE","c":"table","l":5,"ch":[{"t":"TABLE","c":"table","l":6,"ch":[{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"Item 3.01.","l":8},{"t":"TABLE_CELL","c":"Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"8-K,","l":7}]},{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Nasdaq","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Nasdaq","l":8}]}]}]}]}]},{"t":"PARAGRAPH","c":"p","l":3},{"t":"CONTAINER","c":"hr","l":3},{"t":"CONTAINER","c":"div","l":3,"ch":[{"t":"CONTAINER","c":"div","l":4,"ch":[{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"Exchange Act","l":7},{"t":"CONTAINER","c":"span","l":7,"ch":[{"t":"SECTION_TITLE","c":"Exchange Act","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"8-K","l":7}]}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"TABLE","c":"table","l":5,"ch":[{"t":"TABLE","c":"table","l":6,"ch":[{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"Item 3.03.","l":8},{"t":"TABLE_CELL","c":"Material Modification to Rights of Security Holders.","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"8-K","l":7}]}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"TABLE","c":"table","l":5,"ch":[{"t":"TABLE","c":"table","l":6,"ch":[{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"Item 5.01.","l":8},{"t":"TABLE_CELL","c":"Changes in Control of Registrant.","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"8-K","l":7}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"As a result of the Merger, at the Effective Time, a change in control of the Company occurred, and the Company became a wholly-owned subsidiary of Parent. Parent funded the consideration payable in connection with the Merger and paid the fees and expenses required to be paid at the Closing Date of the Merger by Parent and Merger Sub under the A&R Merger Agreement, with debt and equity financing.","l":6}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"TABLE","c":"table","l":5,"ch":[{"t":"TABLE","c":"table","l":6,"ch":[{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"Item 5.02.","l":8},{"t":"TABLE_CELL","c":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"Pursuant to the terms of the A&R Merger Agreement, at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company. These resignations were in connection with the Merger and not as a result of any disagreements between the Company and the resigning individuals or any matters related to the Company’s operations, policies or practices.","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"As of the Effective Time, in accordance with the A&R Merger Agreement, Jeffery A Bedard became the sole director of the Company.","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"Pursuant to the terms of the A&R Merger Agreement, the officers of Merger Sub immediately prior to the Effective Time became the officers of the surviving corporation, effective as of the Effective Time. The officers of Merger Sub immediately prior to the Effective Time were Jeffery A Bedard as Chief Executive Officer, Nadeem Moiz as President, Chief Financial Officer and Chief Operating Officer, and Shellie L. Hammock as Executive Vice President, General Counsel and Secretary. Following completion of the Merger, all of the incumbent officers of the Company, as of immediately prior to the effectiveness of the Merger, were removed as officers of the Company.","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"Biographical and other information with respect to Jeffery A Bedard, Nadeem Moiz, and Shellie L. Hammock is set forth in Schedule I to the Offer to Purchase, a copy of which is attached as Exhibit (a)(1)(A) to the Tender Offer Statement on Schedule TO filed with the SEC by Parent on December 12, 2024 and is incorporated herein by reference.","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"8-K","l":7}]}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"TABLE","c":"table","l":5,"ch":[{"t":"TABLE","c":"table","l":6,"ch":[{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"Item 5.03.","l":8},{"t":"TABLE_CELL","c":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","l":8}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"CONTAINER","c":"span","l":6,"ch":[{"t":"SECTION_TITLE","c":"8-K,","l":7}]}]}]}]},{"t":"PARAGRAPH","c":"p","l":3},{"t":"CONTAINER","c":"hr","l":3},{"t":"CONTAINER","c":"div","l":3,"ch":[{"t":"CONTAINER","c":"div","l":4,"ch":[{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"Item 7.01. Regulation FD Disclosure.","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"On February 6, 2025, the Parent issued a press release announcing the completion of the Merger. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"Item 9.01 Financial Statements and Exhibits.","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"(d) Exhibits","l":6}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"TABLE","c":"table","l":5,"ch":[{"t":"TABLE","c":"table","l":6,"ch":[{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"ExhibitNo.","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"Description","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"2.1","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"Amended and Restated Agreement and Plan of Merger, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and Revance Therapeutics, Inc., dated as of December 7, 2024 (incorporated by reference to Exhibit 2.1 to the Form8-Kfiled by Revance with the SEC on December 9, 2024).","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"2.2","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"Amendment to the Amended and Restated Agreement and Plan of Merger, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and Revance Therapeutics, Inc., dated as of December 11, 2024 (incorporated by reference to Exhibit 2.1 to the Form8-Kfiled by Revance with the SEC on December 12, 2024).","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"2.3","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"Amendment No. 2 to the Amended and Restated Agreement and Plan of Merger, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and Revance Therapeutics, Inc., dated as of January 17, 2025 (incorporated by reference to Exhibit 2.1 to the Form8-Kfiled by Revance with the SEC on January 21, 2025).","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"3.1","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"Amended and Restated Certificate of Incorporation of Revance Therapeutics, Inc.","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"3.2","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"Amended and RestatedBy-Lawsof Revance Therapeutics, Inc.","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"4.1","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"First Supplemental Indenture, by and among Revance Therapeutics, Inc. and U.S. Bank Trust Company, National Association, dated as of February 6, 2025.","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"99.1","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"Press Release issued by Crown Laboratories, Inc., dated February 6, 2025.","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"99.2","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"Schedule I: Directors and Executive Officers of Crown, Merger Sub and Certain Related Parties (incorporated by reference to Exhibit (a)(1)(A) to the Tender Offer Statement on Schedule TO filed by Crown with the SEC on December 12, 2024).","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"","l":8}]},{"t":"TABLE_ROW","c":"tr","l":7,"ch":[{"t":"TABLE_CELL","c":"104","l":8},{"t":"TABLE_CELL","c":"","l":8},{"t":"TABLE_CELL","c":"Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.","l":8}]}]}]}]}]},{"t":"PARAGRAPH","c":"p","l":3},{"t":"CONTAINER","c":"hr","l":3},{"t":"CONTAINER","c":"div","l":3,"ch":[{"t":"CONTAINER","c":"div","l":4,"ch":[{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"SIGNATURES","l":6}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.","l":6}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"CONTAINER","c":"div","l":5,"ch":[{"t":"TABLE","c":"table","l":6,"ch":[{"t":"TABLE","c":"table","l":7,"ch":[{"t":"TABLE_ROW","c":"tr","l":8,"ch":[{"t":"TABLE_CELL","c":"","l":9},{"t":"TABLE_CELL","c":"","l":9},{"t":"TABLE_CELL","c":"","l":9}]},{"t":"TABLE_ROW","c":"tr","l":8,"ch":[{"t":"TABLE_CELL","c":"Revance Therapeutics, Inc.","l":9}]},{"t":"TABLE_ROW","c":"tr","l":8,"ch":[{"t":"TABLE_CELL","c":"","l":9},{"t":"TABLE_CELL","c":"","l":9}]},{"t":"TABLE_ROW","c":"tr","l":8,"ch":[{"t":"TABLE_CELL","c":"By:","l":9},{"t":"TABLE_CELL","c":"","l":9},{"t":"TABLE_CELL","c":"/s/ Jeffery A. Bedard","l":9}]},{"t":"TABLE_ROW","c":"tr","l":8,"ch":[{"t":"TABLE_CELL","c":"Name:","l":9},{"t":"TABLE_CELL","c":"","l":9},{"t":"TABLE_CELL","c":"Jeffery A. Bedard","l":9}]},{"t":"TABLE_ROW","c":"tr","l":8,"ch":[{"t":"TABLE_CELL","c":"Title:","l":9},{"t":"TABLE_CELL","c":"","l":9},{"t":"TABLE_CELL","c":"Chief Executive Officer","l":9}]}]}]}]},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"Date: February 6, 2025","l":6}]},{"t":"PARAGRAPH","c":"p","l":5},{"t":"PARAGRAPH","c":"p","l":5,"ch":[{"t":"SECTION_TITLE","c":"6","l":6}]}]}]}]}]}]}